EUVIMEDEUVIMED entdecken
MetaanalyseÜbersichtsarbeitOpen Access · CC BY 4.0

The Diagnostic Power of Circulating miR-1246 in Screening Cancer: An Updated Meta-analysis

Khanh Quang Huynh iD, Anh Tuan Le, Thang Thanh Phan iD, Toan Trong Ho, Suong Phuoc Pho, Hang Thuy Nguyen, Binh Thanh Le, Thuc Tri Nguyen, Son Truong Nguyen

Oxidative Medicine and Cellular Longevity · 2023

DOI: 10.1155/2023/8379231 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Oxidative Medicine and Cellular Longevity, 2023. Verfasst von Khanh Quang Huynh und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Breast Unit, Cancer Center, Cho Ray Hospital, HCMC 700000, Vietnam. Hauptthemen laut MEDLINE: Circulating MicroRNA, Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma, MicroRNAs. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

MicroRNA-1246 (miR-1246), an oncomiR that regulates the expression of multiple cancer-related genes, has been attracted and studied as a promising indicator of various tumors. However, diverse conclusions on diagnostic accuracy have been shown due to the small sample size and limited studies included. This meta-analysis is aimed at systematically assessing the performance of extracellular circulating miR-1246 in screening common cancers.

Methods

We searched the PubMed/MEDLINE, Web of Science, Cochrane Library, and Google Scholar databases for relevant studies until November 28, 2022. Then, the summary receiver operating characteristic (SROC) curves were drawn and calculated area under the curve (AUC), diagnostic odds ratio (DOR), sensitivity, and specificity values of circulating miR-1246 in the cancer surveillance.

Results

After selection and quality assessment, 29 eligible studies with 5914 samples (3232 cases and 2682 controls) enrolled in the final analysis. The pooled AUC, DOR, sensitivity, and specificity of circulating miR-1246 in screening cancers were 0.885 (95% confidence interval (CI): 0.827-0.892), 27.7 (95% CI: 17.1-45.0), 84.2% (95% CI: 79.4-88.1), and 85.3% (95% CI: 80.5-89.2), respectively. Among cancer types, superior performance was noted for breast cancer ( AUC = 0.950 , DOR = 98.5 ) compared to colorectal cancer ( AUC = 0.905 , DOR = 47.6 ), esophageal squamous cell carcinoma ( AUC = 0.757 , DOR = 8.0 ), hepatocellular carcinoma ( AUC = 0.872 , DOR = 18.6 ), pancreatic cancer ( AUC = 0.767 , DOR = 12.3 ), and others ( AUC = 0.887 , DOR = 27.5 , P = 0.007 ). No significant publication bias in DOR was observed in the meta-analysis (funnel plot asymmetry test with P = 0.652 ; skewness value = 0.672 , P = 0.071 ).

Conclusion

Extracellular circulating miR-1246 may serve as a reliable biomarker with good sensitivity and specificity in screening cancers, especially breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Circulating MicroRNAEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaMicroRNAsBreast NeoplasmsLiver NeoplasmsHumansFemaleEarly Detection of CancerBiomarkers, Tumor

Substanzen

Circulating MicroRNAMicroRNAsBiomarkers, TumorMIRN1246 microRNA, human

Autor:innen und Institutionen

  • The Breast Unit, Cancer Center, Cho Ray Hospital, HCMC 700000, Vietnam.
  • Department of Chemo-Radiotherapy, Cancer Center, Cho Ray Hospital, HCMC 700000, Vietnam.
  • The Laboratory D Unit, Cancer Center, Cho Ray Hospital, HCMC 700000, Vietnam.
  • Department of Clinical Pathology, Cho Ray Hospital, HCMC 700000, Vietnam.
  • Department of General Director, Cho Ray Hospital, HCMC 700000, Vietnam.

ORCID-Profile: Khanh Quang Huynh, Thang Thanh Phan

Zitieren

APA

Huynh, K. Q., Le, A. T., Phan, T. T., Ho, T. T., Pho, S. P., Nguyen, H. T., Le, B. T., Nguyen, T. T., & Nguyen, S. T. (2023). The Diagnostic Power of Circulating miR-1246 in Screening Cancer: An Updated Meta-analysis. Oxidative Medicine and Cellular Longevity. https://doi.org/10.1155/2023/8379231

Vancouver

Huynh KQ, Le AT, Phan TT, Ho TT, Pho SP, Nguyen HT, et al. The Diagnostic Power of Circulating miR-1246 in Screening Cancer: An Updated Meta-analysis. Oxidative Medicine and Cellular Longevity. 2023. doi:10.1155/2023/8379231

BibTeX
@article{Huynh2023,
  author = {Huynh, Khanh Quang and Le, Anh Tuan and Phan, Thang Thanh and Ho, Toan Trong and Pho, Suong Phuoc and Nguyen, Hang Thuy and Le, Binh Thanh and Nguyen, Thuc Tri and Nguyen, Son Truong},
  title = {The Diagnostic Power of Circulating miR-1246 in Screening Cancer: An Updated Meta-analysis},
  journal = {Oxidative Medicine and Cellular Longevity},
  year = {2023},
  doi = {10.1155/2023/8379231}
}
Kostenlos starten →